Original ArticlesPrognostic Significance in Substaging of T1 Urinary Bladder Urothelial Carcinoma on Transurethral ResectionChang, Wei-Chin MD*; Chang, Yen-Hwa MD, PhD†; Pan, Chin-Chen MD*,‡ Author Information *Department of Pathology †Division of Urology, Department of Surgery, Taipei Veterans General Hospital ‡Department of Pathology, National Yang-Ming University, Taipei, Taiwan Conflicts of Interest and Source of Funding: This study was supported by a grant from the Taipei Veterans General Hospital (#V100C-009). The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article. Correspondence: Chin-Chen Pan, MD, Department of Pathology, Taipei Veterans General Hospital, No. 201, Shi-Pai Rd, Sec. 2, Taipei 11217, Taiwan (e-mail: [email protected]). Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website, www.ajsp.com. The American Journal of Surgical Pathology: March 2012 - Volume 36 - Issue 3 - p 454-461 doi: 10.1097/PAS.0b013e31823dafd3 Buy SDC Metrics Abstract T1 papillary urothelial carcinomas of the urinary bladder run a variable clinical course, and an effective substaging system has not been defined yet. This study was conducted to devise an easy-to-use substaging method and to validate its prognostic value in T1 cancer on transurethral resection specimens. A total of 103 cases of T1 low-grade papillary urothelial carcinoma and 406 cases of T1 high-grade papillary urothelial carcinoma from a series of 1515 non-muscle–invasive bladder tumors treated by transurethral resection were studied. Substaging was performed using 0.5, 1.0, and 1.5 mm as thresholds to distinguish extensive from focal invasion. Correlations to recurrence, progression, cancer-specific mortality, and all-cause mortality were explored and compared with Ta tumors. All lamina propria invasions in low-grade papillary urothelial carcinomas were confined to 1.0 mm. The proportions of T1 high-grade papillary urothelial carcinoma invading beyond 0.5, 1.0 (T1>1 mm), and 1.5 mm were 53%, 32%, and 27%, respectively. No prognostic differences were found between Ta and T1 low-grade papillary urothelial carcinomas. T1>1 mm high-grade papillary urothelial carcinomas were associated with significantly greater risks for recurrence, progression, cancer-specific mortality, and all-cause mortality compared with T1≤1 mm and Ta tumors. Comparable statistical results could be obtained using 0.5 and 1.5 mm as cutoff points, but we recommend using 1.0 mm for practical consideration. Taking all non-muscle–invasive urothelial neoplasms of the bladder into consideration, 5 prognostically distinct categories can be established: (1) papillary urothelial neoplasms of low malignant potential; (2) low-grade papillary urothelial carcinoma Ta/1; (3) high-grade papillary urothelial carcinoma Ta; (4) high-grade papillary urothelial carcinoma T1≤1 mm; and (5) high-grade papillary urothelial carcinoma T1>1 mm. Our study demonstrates that the substaging of T1 bladder cancer is feasible, based on the evaluation of transurethral resection specimens, and can provide more precise prognostic information to identify a subset of patients with a more unfavorable prognosis. © 2012 Lippincott Williams & Wilkins, Inc.